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Many ubiquitous yeast are primarily pathogens for immunocompromised patients, individuals with 
AIDS and organ transplanted are at high risk of cryptococcosis and candidiasis. 
In this setting, fungal infections are particularly difficult to treat because antifungal therapy usually 
does not eradicate the infection and require lifelong treatment with antifungal drugs. 
Consequently, the need for novel antifungal agents for opportunistic infections is apparent in light 
of significant problems associated with current drugs and makes the development of new drug 
entities all more urgent. 
We have reported that some 3-(3-alkyl-4-nitroso-1H-5-pyrazolyl)-5-R-isoxazoles [1] and the 
isomeric 5-(1-alkyl-4-nitroso-1H-3-pyrazolyl)-3-R-isoxazoles [2] showed in vitro potent antifungal 
activity at non cytotoxic concentrations. 
This antifungal activity was correlated to: 1) the interaction of the isoxazolic nitrogen with the alkyl 
group bound to the pyrazolyl nitrogen; 2) the cis or trans configuration adopted by the nitroso 
group with respect to the alkyl chain bound to the pyrazolic nitrogen and perpendicularly folded to 
the molecular plane. 
To verify this hypothesis, we synthesized compounds in which the isoxazole was substituted by a 
pyrazole moiety, leading to the new isomeric series I and II.  
 
 
 
 
R’:CH2CH2CH3; R:  a=H, b=CH3; c=CH2CH3 
 
The title compounds  tested in vitro for antifungal activity against C. Neoformans and C. Krusei, 
displayed an interesting antifungal activity, in particular compound Ib was 2 and 32 fold more 
potent than Amphotericin B and Fluconazole, respectively, against C. krusei, fungus with intrinsic 
resistance to many of antifungal azoles 
These results suggest that, depending on the heterocyclic molecule bound to the 5 position of 1H-1-
R-4-nitrosopyrazoles, it is possible to modulate the antifungal activity of 4-nitrosopyrazoles. 
In vitro metabolism studies and in vivo assay are in progress for all described compounds. 
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